Lisata Therapeutics Inc. (NASDAQ: LSTA) Stock Information | RedChip

Lisata Therapeutics Inc. (NASDAQ: LSTA) Listen to this Section


$2.85
-0.0400 ( -1.38% ) 3.0K

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Market Data


Open


$2.85

Previous close


$2.89

Volume


3.0K

Market cap


$23.68M

Day range


$2.78 - $2.89

52 week range


$1.95 - $3.83

Insider Ownership Transactions

Total Amount Purchased: -222,334.00 | $ -633,651.90

Date Type Amount Purchased Purchaser
2024-01-12 Sale -1026.00 Mazzo David J
2024-01-11 Sale -19480.00 KLOSK STEVEN M
2024-01-11 Sale -19480.00 HENSON HEIDI
2024-01-11 Sale -19480.00 AZAB MOHAMMAD
2024-01-11 Sale -94000.00 Mazzo David J
2024-01-11 Sale -19480.00 BROWN GREGORY B
2024-01-11 Sale -19480.00 Flowers Cynthia Louise
2024-01-11 Sale -27000.00 Buck Kristen K
2023-09-05 Sale -2908.00 Buck Kristen K

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 65 Aug 12, 2024
10-q Quarterly Reports 80 Aug 12, 2024
8-k 8K-related 13 Jun 27, 2024
8-k 8K-related 68 May 09, 2024
10-q Quarterly Reports 82 May 09, 2024
def Proxies and info statements 7 Apr 29, 2024
3 Insider transactions 2 Apr 24, 2024
8-k 8K-related 13 Apr 17, 2024
ars Annual reports 1 Mar 28, 2024
10-k Annual reports 227 Feb 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.